Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with type 1 diabetes
Bolli G.B., Songini M., Trovati M., Del Prato S., Ghirlanda G., Cordera R., et al. Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with type 1 diabetes. Nutr Metab Cardiovasc Dis 19 8 (2009) 571-579
Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study
Temple R., Aldridge V., Greenwood R., Heyburn P., Sampson M., and Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ 325 7375 (2002) 1275-1276
Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells
Weinstein D., Simon M., Yehezkel E., Laron Z., and Werner H. Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells. Diabet Metab Res Rev 25 1 (2009) 41-49
Perinatal outcomes associated with the use of glargine during pregnancy
Di Cianni G., Torlone E., Lencioni C., Bonomo M., Di Benedetto A., Napoli A., et al. Perinatal outcomes associated with the use of glargine during pregnancy. Diabet Med 25 8 (2008) 993-996